News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rosenblatt Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Rosenblatt Michael (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.7, valued at
$68k
|
|
| 05/23/2022 |
3
| Rosenblatt Michael (Director) has filed a Form 3 on Axcella Health Inc. |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2021 |
4
| Rosenblatt Michael (Director) has filed a Form 4 on Brooks Automation, Inc.|
Txns:
| Sold 2,831 shares
@ $114.13, valued at
$323.1k
|
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $23.25, valued at
$581.3k
|
|
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2020 |
4
| Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $6.22, valued at
$155.5k
|
|
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $16.27, valued at
$406.8k
|
|
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2018 |
4
| Rosenblatt Michael (Director) has filed a Form 4 on BROOKS AUTOMATION INC|
Txns:
| Granted 1,018 shares
@ $0 |
|
| 09/11/2018 |
3
| Rosenblatt Michael (Director) has filed a Form 3 on BROOKS AUTOMATION INC |
| 07/18/2018 |
4
| Rosenblatt Michael (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $23, valued at
$575k
|
|
| 07/17/2018 |
3
| Rosenblatt Michael (Director) has filed a Form 3 on Rubius Therapeutics, Inc. |
| 05/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/08/2013 |
4
| Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Exercised 4,479 shares
@ $0
Paid exercise price by delivering 2,323 shares
@ $44.98, valued at
$104.5k
Granted 48,309 options to buy
@ $44.98, valued at
$2.2M
Exercised 4,479 restricted stock units
@ $44.98, valued at
$201.5k
|
|
| 02/27/2013 |
4
| Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Granted 5,392 shares
@ $42.52, valued at
$229.3k
|
|
| 05/04/2012 |
4
| Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Granted 3,818 restricted stock units
@ $0
Granted 54,845 options to buy
@ $39.29, valued at
$2.2M
|
|
| 05/06/2011 |
4
| Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Granted 4,103 restricted stock units
@ $0
Granted 55,970 options to buy
@ $36.56, valued at
$2M
|
|
| 05/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2010 |
4
| Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Granted 15,000 restricted stock units
@ $0
Granted 20,000 options to buy
@ $37.49, valued at
$749.8k
|
|
| 12/16/2009 |
3
| Rosenblatt Michael (Exec V-P & Chief Med Officer) has filed a Form 3 on Merck & Co. Inc. |
|
|